Insights On Outsourced Drug Development

  1. A Solvent-Free, Fusion-Based ASD Manufacturing Process 3/5/2024

    Explore a solvent-free alternative for the production of amorphous solid dispersions (ASDs) that not only improves manufacturability but also reduces the carbon footprint of ASD manufacturing.

  2. Formulation Considerations For The Development Of High Concentration Biopharmaceuticals 9/11/2024

    This session addresses key obstacles—such as opalescence, viscosity, and aggregation—and present real-world case studies on how composition changes during the concentration process can be effectively characterized.

  3. Reliable And Reproducible Preclinical Rodent Models Of MASH 3/28/2025

    Our preclinical studies highlight Elafibranor's potential in treating MASH and its progression to hepatocellular carcinoma, warranting further development.

  4. DSS-Induced IBD Mouse Model For Preclinical Drug Screening 3/27/2025

    Leverage our chemically induced murine model of Inflammatory Bowel Disease to accelerate your research on IBD and explore potential therapeutic interventions.

  5. Leveraging Innovative Analytics To Ensure The Thermal Stability Of mAb Drug Products 9/23/2024

    Uncover how innovative Rapid Screening-Differential Scanning Calorimeter technology is enabling robust analysis and regulatory compliance by ensuring the thermal stability of antibody drug products.

  6. Support For Your Production Challenges 7/15/2024

    Ensure your manufacturing operations run smoothly and efficiently by collaborating with experts to tackle production, processing, or quality control issues.

  7. Bleomycin-Induced Scleroderma Mouse Model For Preclinical Testing 3/27/2025

    Get an in-depth overview of the bleomycin-induced scleroderma model, detailing its key specifications and presenting significant findings observed following bleomycin administration in study animals.

  8. Accelerating The Regulatory Approval Process Of Biosimilars 5/13/2025

    Leverage the power of pharmacodynamic biomarkers to streamline biosimilar development and accelerate regulatory approval with greater efficiency and confidence.

  9. Characterization Of Pharmaceutical Materials With Modulated DSC 12/30/2024

    Modulated DSC addresses challenges in pharmaceutical material characterization, enabling precise analysis of glass transitions, and overlapping transitions, enhancing insights beyond standard DSC.

  10. Manual Whole-Cell Patch Clamp Assay For Screening NCE's Against Voltage Gated Ion-Channels 5/13/2025

    Ensure the cardiac safety of your drug candidates by leveraging manual whole-cell patch-clamping to assess their impact on hERG channel interactions and prevent potential QT prolongation risks.